Sanofi to take 26.4% stake in Cheplapharm in portfolio swap
Sanofi will transfer a portfolio of 20 developed medicines and three manufacturing sites to Cheplapharm in exchange for a 26.4% equity stake.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.